 |
인쇄하기
취소
|
Ostec wins U.S. patent for new anticancer compounds
Ostec Inc., a local biopharmaceutical company, said Wednesday that it has recently obtained the U.S. patent for new anticancer compounds.
The patented compounds, which have been discovered through a 4-year intensive study by Ostec and U.S. based Genosco’ Boston laboratory, are novel selective inhibitors of FLT3 kinases for acute myeloid leukemia (AML).
The compounds have therapeutic benef...
The patented compounds, which have been discovered through a 4-year intensive study by Ostec and U.S. based Genosco’ Boston laboratory, are novel selective inhibitors of FLT3 kinases for acute myeloid leukemia (AML).
The compounds have therapeutic benef...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.